Use of bisphosphonates and raloxifene and risk of deep venous thromboembolism and pulmonary embolism

P Vestergaard, K Schwartz, E M Pinholt, Lars Rejnmark, Leif Mosekilde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstract

Prior studies have associated raloxifene and strontium ranelate with deep venous thromboembolism and pulmonary embolism. In a cohort study, we observed an increased risk also with the bisphosphonates. However, the increase was present already before the start of bisphosphonates pointing at an effect of the underlying condition.
OriginalsprogEngelsk
TidsskriftOsteoporosis International
Vol/bind21
Udgave nummer9
Sider (fra-til)1591-1597
ISSN0937-941X
DOI
StatusUdgivet - 1. sep. 2010
Udgivet eksterntJa

Fingeraftryk

Dyk ned i forskningsemnerne om 'Use of bisphosphonates and raloxifene and risk of deep venous thromboembolism and pulmonary embolism'. Sammen danner de et unikt fingeraftryk.

Citationsformater